Archive: 19/12/2018
Targeted treatment slows progression of rare connective tissue tumor
In a phase three clinical trial, a drug called sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients who completed treatment, a significant increase in progression-free survival compared ...
Dec 19, 2018
Can Facebook advertising prevent cancer?
Is there ever a truly good time for a colonoscopy? Even with the recommendation of a primary care physician, it's easy to procrastinate or simply forget to schedule an appointment with your friendly neighborhood endoscopist. ...
Dec 19, 2018